These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25030027)

  • 1. Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity.
    Savcheniuk O; Kobyliak N; Kondro M; Virchenko O; Falalyeyeva T; Beregova T
    BMC Complement Altern Med; 2014 Jul; 14():247. PubMed ID: 25030027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention.
    Kobyliak N; Falalyeyeva T; Virchenko O; Mykhalchyshyn G; Bodnar P; Spivak M; Yankovsky D; Beregova T; Ostapchenko L
    BMC Gastroenterol; 2016 Mar; 16():34. PubMed ID: 26976285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Probiotics and Smectite in Rats with Non-Alcoholic Fatty Liver Disease.
    Kobyliak N; Abenavoli L; Falalyeyeva T; Beregova T
    Ann Hepatol; 2018; 17(1):153-161. PubMed ID: 29311399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics Supplemented with Omega-3 Fatty Acids are More Effective for Hepatic Steatosis Reduction in an Animal Model of Obesity.
    Kobyliak N; Falalyeyeva T; Bodnar P; Beregova T
    Probiotics Antimicrob Proteins; 2017 Jun; 9(2):123-130. PubMed ID: 27660157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of probiotics for monosodium glutamate-induced obesity: dietology concerns and opportunities for prevention.
    Savcheniuk OA; Virchenko OV; Falalyeyeva TM; Beregova TV; Babenko LP; Lazarenko LM; Demchenko OM; Bubnov RV; Spivak MY
    EPMA J; 2014 Jan; 5(1):2. PubMed ID: 24410812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of polyphenol compounds melanin on NAFLD/NASH prevention.
    Belemets N; Kobyliak N; Virchenko O; Falalyeyeva T; Olena T; Bodnar P; Savchuk O; Galenova T; Caprnda M; Rodrigo L; Skladany L; Delev D; Opatrilova R; Kruzliak P; Beregova T; Ostapchenko L
    Biomed Pharmacother; 2017 Apr; 88():267-276. PubMed ID: 28110193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics for experimental obesity prevention: focus on strain dependence and viability of composition.
    Kobyliak N; Falalyeyeva T; Beregova T; Spivak M
    Endokrynol Pol; 2017; 68(6):659-667. PubMed ID: 29022648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics and nutraceuticals as a new frontier in obesity prevention and management.
    Kobyliak N; Falalyeyeva T; Boyko N; Tsyryuk O; Beregova T; Ostapchenko L
    Diabetes Res Clin Pract; 2018 Jul; 141():190-199. PubMed ID: 29772287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenugreek Seed Extract Prevents Fat Deposition in Monosodium Glutamate (MSG)-Obese Rats.
    Kumar P; Bhandari U
    Drug Res (Stuttg); 2016 Apr; 66(4):174-80. PubMed ID: 26198036
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    França LM; Coêlho CFF; Freitas LNC; Souza ILS; Chagas VT; Debbas V; de Lima TM; de Souza HP; Laurindo FRM; Paes AMA
    Oxid Med Cell Longev; 2019; 2019():9417498. PubMed ID: 31015892
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of stem bark aqueous extract of Fagara tessmannii Engl (Rutaceae) on cardiovascular risks related to monosodium glutamate-induced obesity in rat: In vivo and in vitro assessments.
    Fouda YB; Ngo Lemba Tom E; Atsamo AD; Bonabe C; Dimo T
    J Ethnopharmacol; 2020 Oct; 260():112972. PubMed ID: 32446928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term ingestion of monosodium L-glutamate did not induce obesity, dyslipidemia or insulin resistance: a two-generation study in mice.
    Nakamura H; Kawamata Y; Kuwahara T; Smriga M; Sakai R
    J Nutr Sci Vitaminol (Tokyo); 2013; 59(2):129-35. PubMed ID: 23727643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome.
    Sasaki Y; Shimada T; Iizuka S; Suzuki W; Makihara H; Teraoka R; Tsuneyama K; Hokao R; Aburada M
    Eur J Pharmacol; 2011 Jul; 662(1-3):1-8. PubMed ID: 21549692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monosodium glutamate neonatal intoxication associated with obesity in adult stage is characterized by chronic inflammation and increased mRNA expression of peroxisome proliferator-activated receptors in mice.
    Roman-Ramos R; Almanza-Perez JC; Garcia-Macedo R; Blancas-Flores G; Fortis-Barrera A; Jasso EI; Garcia-Lorenzana M; Campos-Sepulveda AE; Cruz M; Alarcon-Aguilar FJ
    Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):406-13. PubMed ID: 21205225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of monosodium glutamate-induced obesity in spontaneously hypertensive rats vs. Wistar Kyoto rats: serum leptin and blood flow to brown adipose tissue.
    Iwase M; Ichikawa K; Tashiro K; Iino K; Shinohara N; Ibayashi S; Yoshinari M; Fujishima M
    Hypertens Res; 2000 Sep; 23(5):503-10. PubMed ID: 11016806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early onset and progression of non-alcoholic fatty liver disease in young monosodium l-glutamate-induced obese mice.
    Coelho CFF; França LM; Nascimento JR; Dos Santos AM; Azevedo-Santos APS; Nascimento FRF; Paes AMA
    J Dev Orig Health Dis; 2019 Apr; 10(2):188-195. PubMed ID: 29855396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of CB1 receptor blockade on monosodium glutamate induced hypometabolic and hypothalamic obesity in rats.
    Chen W; Chen Z; Xue N; Zheng Z; Li S; Wang L
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):721-32. PubMed ID: 23620336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-fostering reduces obesity induced by early exposure to monosodium glutamate in male rats.
    Miranda RA; da Silva Franco CC; de Oliveira JC; Barella LF; Tófolo LP; Ribeiro TA; Pavanello A; da Conceição EP; Torrezan R; Armitage J; Lisboa PC; de Moura EG; de Freitas Mathias PC; Vieira E
    Endocrine; 2017 Jan; 55(1):101-112. PubMed ID: 27116693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease.
    Collison KS; Maqbool Z; Saleh SM; Inglis A; Makhoul NJ; Bakheet R; Al-Johi M; Al-Rabiah R; Zaidi MZ; Al-Mohanna FA
    J Lipid Res; 2009 Aug; 50(8):1521-37. PubMed ID: 19001666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.